Latest debt-to-equity ratio
Catalyst Pharmaceuticals Debt-to-equity ratio
Direct answer
Catalyst Pharmaceuticals's debt-to-equity ratio is 0.27%.
The verified market snapshot reports 0.27%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 16, 2026.
Get free Catalyst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.27%
Explore related company data
View Catalyst Pharmaceuticals's market capitalizationView Catalyst Pharmaceuticals's p/e ratioView Catalyst Pharmaceuticals's price-to-book ratioView Catalyst Pharmaceuticals's return on equityView Catalyst Pharmaceuticals's 52-week price rangeView Catalyst Pharmaceuticals's revenue growthView Catalyst Pharmaceuticals's profit marginView all Catalyst Pharmaceuticals key metricsReturn to Catalyst Pharmaceuticals profile